SCHEMBL807154

SCHEMBL807154

COc1ncc(-c2ccc3nc(N)c(-c4ccc(C(N)=O)cc4)cc3c2)cc1NS(=O)(=O)c1ccc(F)cc1F

nearest known ligand 0.82

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PIK3CG P48736 10/20 0.82
PI4KA P42356 7/20 0.82
PIK3CA P42336 13/20 0.64
MTOR P42345 8/20 0.64
PIK3CD O00329 3/20 0.57
PIK3CB P42338 3/20 0.57
PIK3R1 P27986 2/20 0.57
PRKDC P78527 1/20 0.57
PDE4D Q08499 1/20 0.57
RICTOR Q6R327 1/20 0.57
RPTOR Q8N122 1/20 0.57
PIK3C3 Q8NEB9 1/20 0.57
PIP4K2C Q8TBX8 1/20 0.57
MAPKAP1 Q9BPZ7 1/20 0.57
MLST8 Q9BVC4 1/20 0.57
IRAK3 Q9Y616 1/20 0.57
HDAC1 Q13547 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL789386 0.94 PIK3CG (0.82) PIK3CGPI4KAPIK3CAMTORPIK3CD
SCHEMBL791065 0.93 PIK3CG (0.80) PIK3CGPI4KAPIK3CAMTORPIK3CD
SCHEMBL807070 0.92 PIK3CG (0.80) PIK3CGPI4KAPIK3CAMTORPIK3CD
SCHEMBL790298 0.92 PIK3CG (0.79) PIK3CGPI4KAPIK3CAMTORPIK3CD
SCHEMBL789570 0.90 PIK3CG (1.00) PIK3CGPI4KAPIK3CAMTORPIK3CD
SCHEMBL790975 0.90 PIK3CG (0.77) PIK3CGPI4KAPIK3CAMTORPIK3CD
SCHEMBL807106 0.90 PIK3CG (0.76) PIK3CGPI4KAPIK3CAMTORPIK3CD
SCHEMBL807304 0.90 PIK3CG (0.75) PIK3CGPI4KAPIK3CAMTORPIK3CD
SCHEMBL10274761 0.89 PIK3CG (0.75) PIK3CGPI4KAPIK3CAMTORPIK3CD
SCHEMBL791281 0.89 PIK3CG (0.80) PIK3CGPI4KAPIK3CAMTORPIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012037108-A1 AMINOQUINOLINE DERIVATIVES AS ANTIVIRAL AGENTS GLAXOSMITHKLINE LLC (US) 2012-03-22 WO disclosed